Boston Therapeutics, Inc. (BTHE) Begins Enrolling Patients in Phase 2b Trial for PAZ320
Boston Therapeutics announced it has begun enrolling patients in a Phase 2b Trial for its PAZ320 drug today. A total…
Boston Therapeutics announced it has begun enrolling patients in a Phase 2b Trial for its PAZ320 drug today. A total…
Today before the opening bell, Kallo, a healthcare technology company, announced it received confirmation from the Monsieur Directeur General de…
First Titan Energy Corp., an oil and natural gas development company, announced today it is evaluating the merits of an…
StreamTrack has developed a portfolio of tools that help broadcasters and publishers maximize revenues and decrease or eliminate expenses. These…
Raptor Resources Holdings is a holdings company concentrated on mineral resource acquisition, exploration, and development. Working through its two subsidiaries,…
In 2013 there are 33.5 million people playing fantasy sports in the United States alone, according to Fantasy Sports Trade…
Good information security is not a one-size-fits-all proposition. eCrypt Technologies, an emerging provider of military-strength data security solutions, has learned…
Environmentally sustainable energy, infrastructure, and technologies-focused company Pan Global Corp. recently announced it is making significant strides toward its acquisition…
Kallo leverages a suite of technologies to improve the quality and efficiency of care in the $6.3 trillion global healthcare…
California-based International Stem Cell will be hosting a conference call this week to discuss its financial results for the three…